Stassen Michael, Jonuleit Helmut, Müller Christian, Klein Matthias, Richter Christoph, Bopp Tobias, Schmitt Steffen, Schmitt Edgar
Institute of Immunology, Johannes Gutenberg University, Hochhaus am Augustusplatz, D-55101 Mainz, Germany.
J Immunol. 2004 Jul 1;173(1):267-74. doi: 10.4049/jimmunol.173.1.267.
CD25+ T regulatory (Treg) cells play a central role regarding the maintenance of peripheral tolerance via suppression of autoaggressive CD4+ T cells, CD8+ T cells, and Th1 cells. In this study we demonstrate that CD25+ Treg cells can also suppress the differentiation of murine conventional CD4+ T cells toward Th2 cells in a contact-dependent manner. However, the cytokine production and proliferation of established Th2 cells could not be inhibited by freshly isolated CD25+ Treg cells, whereas a strong inhibition of differentiated Th2 cells by in vitro preactivated CD25+ Treg cells could be observed. Inhibition of both conventional CD4+ T cells and Th2 cells is accompanied by a strong enhancement of the expression of FoxP3 in the suppressed T cells. Hence, our study indicates that CD25+ Treg cells have a therapeutic potential for Th2-mediated diseases and suggests a novel mechanism of suppression mediated by the transcriptional repressor FoxP3.
CD25 + 调节性T(Treg)细胞通过抑制自身攻击性CD4 + T细胞、CD8 + T细胞和Th1细胞,在维持外周免疫耐受方面发挥核心作用。在本研究中,我们证明CD25 + Treg细胞也能以接触依赖的方式抑制小鼠传统CD4 + T细胞向Th2细胞的分化。然而,新鲜分离的CD25 + Treg细胞不能抑制已建立的Th2细胞的细胞因子产生和增殖,而体外预激活的CD25 + Treg细胞对分化的Th2细胞有强烈的抑制作用。对传统CD4 + T细胞和Th2细胞的抑制都伴随着被抑制的T细胞中FoxP3表达的强烈增强。因此,我们的研究表明CD25 + Treg细胞对Th2介导的疾病具有治疗潜力,并提示了由转录抑制因子FoxP3介导的一种新的抑制机制。